SCHEMBL22759088

SCHEMBL22759088

C/C=C/CCCCCCCCC(=O)OCCCC/C=C/C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 2/20 0.52
ALDH1A1 P00352 2/20 0.51
CYP3A4 P08684 1/20 0.51
ALOX15 P16050 1/20 0.51
TSHR P16473 1/20 0.51
HSD17B10 Q99714 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
MGLL Q99685 1/20 0.49
PRSS1 P07477 1/20 0.49
PRSS2 P07478 1/20 0.49
PRSS3 P35030 1/20 0.49
FAAH O00519 1/20 0.47
MAPT P10636 1/20 0.47
THRB P10828 1/20 0.47
CNR1 P21554 1/20 0.47
EPHX2 P34913 3/20 0.45
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCD Q05655 1/20 0.44
PRKCA P17252 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547970 1.00 DGKA (0.52) DGKAALDH1A1CYP3A4ALOX15TSHR
SCHEMBL8904237 1.00 DGKA (0.52) DGKAALDH1A1CYP3A4ALOX15TSHR
SCHEMBL22734506 1.00 DGKA (0.52) DGKAALDH1A1CYP3A4ALOX15TSHR
SCHEMBL22734492 1.00 DGKA (0.52) DGKAALDH1A1CYP3A4ALOX15TSHR
SCHEMBL20547969 1.00 DGKA (0.52) DGKAALDH1A1CYP3A4ALOX15TSHR
SCHEMBL21984344 1.00 DGKA (0.52) DGKAALDH1A1CYP3A4ALOX15TSHR
SCHEMBL22734507 1.00 DGKA (0.52) DGKAALDH1A1CYP3A4ALOX15TSHR
SCHEMBL22734505 1.00 DGKA (0.52) DGKAALDH1A1CYP3A4ALOX15TSHR
SCHEMBL22734495 0.96 ALDH1A1 (0.56) DGKAALDH1A1CYP3A4ALOX15TSHR
SCHEMBL22734496 0.96 ALDH1A1 (0.56) DGKAALDH1A1CYP3A4ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11407726-B2 Using stereoretention for the stereoselective formation of e-macrocycles with Ru-based olefin metathesis catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2022-08-09 US disclosed
US-20200385360-A1 USING STEREORETENTION FOR THE STEREOSELECTIVE FORMATION OF E-MACROCYCLES WITH RU-BASED OLEFIN METATHESIS CATALYSTS CALIFORNIA INSTITUTE OF TECHNOLOGY 2020-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200385360-A1 USING STEREORETENTION FOR THE STEREOSELECTIVE FORMATION OF E-MACROCYCLES WITH RU-BASED OLEFIN METATHESIS CATALYSTS OXER1, SPR, DHCR7 DGKA 3890/4885ALDH1A1 1159/4885CYP3A4 81/4885
US-11407726-B2 Using stereoretention for the stereoselective formation of e-macrocycles with Ru-based olefin metathesis catalysts OXER1, SPR, DHCR7 DGKA 3890/4885ALDH1A1 1159/4885CYP3A4 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.